Trailing-twelve-month (TTM) revenue is $8.36 Billion with a year-over-year growth of +14.68%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-27 | $2,010,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q3 FY2026Period ended 2025-12-27 | $2,406,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q4 FY2026Period ended 2026-03-28 | $1,978,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-21 |
| Q1 FY2027Period ended 2026-06-27 | $1,959,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $8,355,200,000 |
Current P/S: $20,684,426,251 market capitalization ÷ $8,355,200,000 TTM revenue = 2.48x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:02.000Z. Latest revenue period ended 2026-06-27.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-27): $1.96B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:55.740Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-27 · USD | FY20222022-04-02 · USD | FY20232023-04-01 · USD | FY20242024-03-30 · USD | FY20252025-03-29 · USD | FY20262026-03-28 · USD |
|---|---|---|---|---|---|---|
| Asia Segment | $1.0B | $1.3B | $1.4B | $1.6B | $1.7B | $2.1B |
| Europe Segment | $1.2B | $1.8B | $1.8B | $2.0B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-27 · USD | FY20222022-04-02 · USD | FY20232023-04-01 · USD | FY20242024-03-30 · USD | FY20252025-03-29 · USD | FY20262026-03-28 · USD |
|---|---|---|---|---|---|---|
| Americas | $2.2B | $3.0B | $3.2B | $3.1B | $3.2B | $3.5B |
| Asia | $1.0B | $1.3B | $1.4B | $1.6B |
$8.36B
$8.36 Billion
+14.68%
vs. $7.29B a year ago (TTM)
+9.57%
5 Year compound annual growth rate
1 Year
+14.68%
3 Year
+8.35%
5 Year
+9.57%
10 Year
+1.19%
15 Year
+2.59%
20 Year
+4.04%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $8.11B | +$1.04B | +14.63% |
| 2025 | $7.08B | +$447.60M | +6.75% |
| 2024 | $6.63B | +$187.80M | +2.91% |
| 2023 | $6.44B | +$225.10M | +3.62% |
| 2022 | $6.22B | +$1.82B | +41.30% |
| 2021 |
TTM Growth
+14.68%
3-Year CAGR
+8.35%
5-Year CAGR
+9.57%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:55.740Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
2026-03-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.2B |
| $2.5B |
| North America Segment | $2.0B | $3.0B | $3.0B | $3.0B | $3.1B | $3.3B |
|---|
| Other Segments | $215M | $183M | $157M | $146M | $145M | $143M |
|---|
| $2.1B |
| Europe | $1.2B | $1.8B | $1.8B | $1.9B | $2.2B | $2.5B |
|---|
| $4.40B |
| ($1.76B) |
| (28.56%) |
| 2020 | $6.16B | ($153.20M) | (2.43%) |
| 2019 | $6.31B | +$130.70M | +2.11% |
| 2018 | $6.18B | ($470.50M) | (7.07%) |
| 2017 | $6.65B | ($752.20M) | (10.16%) |
